Showing 1 - 10 of 38
Four decades ago, the main actors in global health were the World Health Organization (WHO), the United Nations Children's Fund (UNICEF) and the United States of America and Northern European countries (through bilateral cooperation). Today we are witnessing a proliferation of actors in this...
Persistent link: https://www.econbiz.de/10014470063
Persistent link: https://www.econbiz.de/10003552660
This paper proposes a framework for designing an Independent Panel on Evidence for Action on Antimicrobial Resistance (IPEA), responding to the 2025 United Nations General Assembly mandate. Through a comparative analysis of selected international scientific advisory bodies, we identify the...
Persistent link: https://www.econbiz.de/10015425350
This paper examines how the courts in three developing countries (Kenya, South Africa, and India) have addressed the tension between patent rights on pharmaceutical products and the right to health. The paper begins by examining the nature of the relationship between patent rights and the right...
Persistent link: https://www.econbiz.de/10012814511
Competition law may play an important role in drug pricing control by containing high prices derived from economic violations. Since the use of competition tools is not limited by the TRIPS Agreement or other international binding disciplines, there is ample policy room to explore how countries,...
Persistent link: https://www.econbiz.de/10012793471
This paper advances that WHO Member States, having agreed to the objectives of advancing equity and solidarity for future pandemic prevention, preparedness and response, now must operationalize these. The paper offers suggestions for the ongoing WHO processes of: 1) review of recommendations...
Persistent link: https://www.econbiz.de/10012886763
Developing countries will face more complex challenges as infectious disease patterns transform due to climate change and climate variability. These challenges include how to reduce the incidence of malaria (including the significant challenge of resistant malaria), dengue, and other...
Persistent link: https://www.econbiz.de/10012604277
Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine...
Persistent link: https://www.econbiz.de/10012496070
Persistent link: https://www.econbiz.de/10012433977
Persistent link: https://www.econbiz.de/10012433988